Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) FCF Margin (2016 - 2024)

vTv Therapeutics (VTVT) has disclosed FCF Margin for 10 consecutive years, with 28382.35% as the latest value for Q4 2024.

  • Quarterly FCF Margin changed N/A to 28382.35% in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 122523.53% through Sep 2025, down 12018393.0% year-over-year, with the annual reading at 2488.4% for FY2024, N/A changed from the prior year.
  • FCF Margin hit 28382.35% in Q4 2024 for vTv Therapeutics, down from 733.5% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 7844.44% in Q2 2022 to a low of 77628.57% in Q3 2020.
  • Historically, FCF Margin has averaged 30109.08% across 4 years, with a median of 14557.93% in 2024.
  • Biggest five-year swings in FCF Margin: surged 8390829bps in 2020 and later plummeted -7126543bps in 2021.
  • Year by year, FCF Margin stood at 34.57% in 2020, then tumbled by -206161bps to 71300.0% in 2021, then dropped by -7bps to 76444.44% in 2022, then soared by 63bps to 28382.35% in 2024.
  • Business Quant data shows FCF Margin for VTVT at 28382.35% in Q4 2024, 733.5% in Q1 2024, and 76444.44% in Q4 2022.